Why the study?
Although myocardial viability is conceptually intuitive, it has eluded positive benefit in randomized trials, and cardiologists need guidance on whether PET or CMR is most optimum in a given clinical situation.
This review discusses the fundamentals, pros, and cons of PET and CMR for assessing myocardial viability to guide clinical decision-making.
Answers are grounded in this paper and cite their sources.
May inform PET vs CMR selection for viability assessment; leaves open outcome benefits pending randomized trials.
Myocardial viability is an important concept that though conceptualy inituitive however has eluded any positive benefit in a randomised trial situation . The two techniques that are cutting edge and also the most accurate are the PET and CMR . In this review we will try to address the fundamentals and the pros and cons of each technique to enable clinical cardiologists to have an understanding on which technique will be the most optimum in a given clinical situation.
No takes yet. Share an insight, caveat, or question.
Johann Christopher (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: